Shortening the lenght of stay in patients with pneumothorax by pleurodesis with autologous blood.

Shortening the lenght of stay in patients with pneumothorax by pleurodesis with autologous blood. - Autologous blood-patch pleurodesis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30504

Enrollment

Registered

2007-07-10

Start date

2007-03-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

collapsed lung pneumothorax

Interventions

After insertion of chest tube: - Patients in the study group: if after 24 - 36 hours still air leak, pleurodesis with 100 ml autologous blood. - Control group: observation only

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: eligible for the study, need to have tube insertion, air leak > 24 hours after thorax drian is inserted

Exclusion criteria

Exclusion criteria: post-operative pneumothorax, signs of bacteremia, pneumothorax as a result of multitrauma, recurrent pneumothorax

Design outcomes

Primary

Measure	Time frame
Shorten length of stay	—

Secondary

Measure	Time frame
duration of air leak duration of drainage complications fever till 72 hours after pleurodesis fever after 72 hours after pleurodesis empyema positive culture of pleural fluid need to surgical intervention due to persistance of air lek (VATS, thoracotomy) recurrence rate within one month and after one year	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)